Breast-conserving Surgery Without Axillary Surgery and Radiation Versus Mastectomy Plus Axillary Dissection in Elderly Breast Cancer Patients: A Retrospective Study

Overview

Journal Front Oncol

Specialty Oncology

Date 2023 Apr 6

PMID 37020865

Authors

Ying Zhong

Zhe Wang

Yali Xu

Yidong Zhou

Feng Mao

Songjie Shen

Qiang Sun

Affiliations

Soon will be listed here.

Abstract

Background: The high relative mortality rate in elderly breast cancer patients is most likely the result of comorbidities rather than the tumor load. Foregoing axillary lymph node dissection or omitting radiotherapy after breast-conserving surgery (BCS) does not affect the prognosis of elderly breast cancer patients. We sought to assess the safety of breast-conserving surgery without axillary lymph node dissection as well as breast and axillary radiotherapy (BCSNR) in elderly patients with early-stage breast cancer.

Methods: We retrospectively included 541 consecutive breast cancer patients aged over 70 years with clinically negative axillary lymph nodes in one clinical center. Of these patients, 181 underwent mastectomy plus axillary lymph node dissection (MALND) with negative axillary cleaning and 360 underwent BCSNR.

Results: After a median follow-up of 5 years, there was no significant difference between the BCSNR and MALND groups in either distant recurrence-free survival (DRFS) (=0.990) or breast cancer-specific survival (=0.076). Ipsilateral axillary disease was found in 11 (3.1%) patients in the BCSNR group and 3 (1.7%) patients in the MALND group; this difference was not significant (=0.334). We did not observe a significant difference in distant recurrence between the groups (=0.574), with 25 (6.9%) patients in the BCSNR group experiencing distant recurrence compared to 15 (8.3%) patients in the MALND group. Our findings did show a significant difference in ipsilateral breast cancer recurrence (IBTR), with 31 (8.6%) patients in the BCSNR group experiencing IBTR compared to only 2 (1.1%) patients in the MALND group (=0.003).

Conclusion: BCSNR is a safe treatment option for elderly breast cancer patients with clinically negative axillary lymph nodes.

References

Rudenstam C, Zahrieh D, Forbes J, Crivellari D, Holmberg S, Rey P . Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol. 2005; 24(3):337-44. DOI: 10.1200/JCO.2005.01.5784. View

Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378(9804):1707-16. PMC: 3254252. DOI: 10.1016/S0140-6736(11)61629-2. View

Welsh J, Hoskin T, Day C, Habermann E, Goetz M, Boughey J . Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice. Ann Surg Oncol. 2017; 24(10):2881-2888. DOI: 10.1245/s10434-017-5932-1. View

Wolff A, Hammond M, Hicks D, Dowsett M, McShane L, Allison K . Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013; 31(31):3997-4013. DOI: 10.1200/JCO.2013.50.9984. View

Kunkler I, Williams L, Jack W, Cameron D, Dixon J . Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015; 16(3):266-73. DOI: 10.1016/S1470-2045(14)71221-5. View

Jenkins E, Deal A, Anders C, Prat A, Perou C, Carey L . Age-specific changes in intrinsic breast cancer subtypes: a focus on older women. Oncologist. 2014; 19(10):1076-83. PMC: 4200998. DOI: 10.1634/theoncologist.2014-0184. View

Anderson W, Katki H, Rosenberg P . Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst. 2011; 103(18):1397-402. PMC: 3176776. DOI: 10.1093/jnci/djr257. View

Goldhirsch A, Wood W, Coates A, Gelber R, Thurlimann B, Senn H . Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011; 22(8):1736-47. PMC: 3144634. DOI: 10.1093/annonc/mdr304. View

Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V . Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366(9503):2087-106. DOI: 10.1016/S0140-6736(05)67887-7. View

10.

Morgan J, Reed M, Wyld L . Primary endocrine therapy as a treatment for older women with operable breast cancer - a comparison of randomised controlled trial and cohort study findings. Eur J Surg Oncol. 2014; 40(6):676-84. DOI: 10.1016/j.ejso.2014.02.224. View

11.

Wickberg A, Liljegren G, Killander F, Lindman H, Bjohle J, Carlberg M . Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe. Eur J Surg Oncol. 2018; 44(7):951-956. DOI: 10.1016/j.ejso.2018.04.002. View

12.

Johnston S, Kenny F, Syed B, Robertson J, Pinder S, Winterbottom L . A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up. Ann Oncol. 2012; 23(9):2296-2300. DOI: 10.1093/annonc/mdr630. View

13.

Walter L, Covinsky K . Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001; 285(21):2750-6. DOI: 10.1001/jama.285.21.2750. View

14.

Matuschek C, Bolke E, Haussmann J, Mohrmann S, Nestle-Kramling C, Gerber P . The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer- a meta-analysis of randomized trials. Radiat Oncol. 2017; 12(1):60. PMC: 5364687. DOI: 10.1186/s13014-017-0796-x. View

15.

Martelli G, Miceli R, Daidone M, Vetrella G, Cerrotta A, Piromalli D . Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol. 2010; 18(1):125-33. PMC: 3018257. DOI: 10.1245/s10434-010-1217-7. View

16.

de Glas N, Kiderlen M, Bastiaannet E, de Craen A, van de Water W, van de Velde C . Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis. Breast Cancer Res Treat. 2013; 138(2):561-9. DOI: 10.1007/s10549-013-2462-9. View

17.

Gervasoni Jr J, Sbayi S, Cady B . Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data. Ann Surg Oncol. 2007; 14(9):2443-62. DOI: 10.1245/s10434-007-9360-5. View

18.

Taylor C, Correa C, Duane F, Aznar M, Anderson S, Bergh J . Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials. J Clin Oncol. 2017; 35(15):1641-1649. PMC: 5548226. DOI: 10.1200/JCO.2016.72.0722. View

19.

Chung A, Gangi A, Amersi F, Zhang X, Giuliano A . Not Performing a Sentinel Node Biopsy for Older Patients With Early-Stage Invasive Breast Cancer. JAMA Surg. 2015; 150(7):683-4. DOI: 10.1001/jamasurg.2015.0647. View

20.

Vaidya J, Bulsara M, Wenz F . Ischemic heart disease after breast cancer radiotherapy. N Engl J Med. 2013; 368(26):2526-7. DOI: 10.1056/NEJMc1304601. View